Prachaya Nitichaikulvatana, MD

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

18 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nitichaikulvatana’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

18 of 18 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)	Anthem Blue Cross	Listed	Oct 3, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence C175548 · Current

Licensed to practise in California · since 2021 · expires 2027-11-30 · Srinakharinwirot University Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$56,069

Medicare paid this office $56,069 for 240 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	103	$17,755	$114
New patient visit (60+ min)	47	$9,011	$192
New patient visit (60+ min)	51	$7,393	$145
Long return visit (40+ min)	28	$7,060	$172
Return visit (30+ min)	37	$3,520	$84

See all 8 services

Sort by

Every Original Medicare service billed

Return visit (30+ min)	103	$17,755	$114
New patient visit (60+ min)	47	$9,011	$192
New patient visit (60+ min)	51	$7,393	$145
Long return visit (40+ min)	28	$7,060	$172
Return visit (30+ min)	37	$3,520	$84
Long return visit (40+ min)	23	$3,374	$125
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	90	$2,142	$15
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	43	$719	$15

Who their Medicare patients are

240 Original Medicare patients in 2024. Average age 71 · Under 65 17% · 85 and older 8% · Women 68% · Also on Medicaid 25% · Health risk score 1.69. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 63% · Coronary heart disease 31% · Depression 30% · Chronic kidney disease 29% · Diabetes 25% · Cancer 18% · Heart failure 17% · Atrial fibrillation 17% · COPD 15% · Stroke 9% · Dementia 8%.

The office billed $250,828, Medicare allowed $74,728 and paid $56,069; for 618 services of 14 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	240	618	71	1.69	$250,828	$56,069
2023	250	437	71	1.43	$254,987	$50,079
2022	221	647	70	1.35	$184,385	$38,048
2021	308	3,030	68	1.27	$452,280	$93,716
2020	313	2,338	68	1.35	$380,327	$74,353
2019	335	2,958	67	1.39	$549,723	$106,367
2018	346	2,850	67	1.33	$402,633	$82,325
2017	311	2,654	66	1.32	$340,520	$74,461
2016	306	1,778	67	1.20	$274,406	$62,266
2015	294	1,220	67	1.29	$220,283	$54,042
2014	272	1,938	66	1.06	$233,076	$56,299
2013	326	918	63	1.13	$187,387	$54,353

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Sort by

Original Medicare services billed in 2023

New patient visit (60+ min)	96	$15,204	$158
Return visit (30+ min)	100	$11,500	$85
New patient visit (60+ min)	29	$5,126	$177
Return visit (30+ min)	31	$4,882	$114
Long return visit (40+ min)	38	$4,780	$114
Long return visit (40+ min)	14	$3,047	$152
Initial hospital care with moderate level of medical decision making at least 75 minutes	12	$1,919	$160
Telehealth originating site facility fee	12	$382	$22

2022: 5 services

Sort by

Original Medicare services billed in 2022

New patient visit (60+ min)	60	$9,867	$164
Long return visit (40+ min)	31	$5,519	$131
New patient visit (60+ min)	23	$4,853	$211
Return visit (30+ min)	34	$3,796	$90
Short return visit (20+ min)	85	$3,056	$36

2021: 10 services

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	210	$26,992	$89
Injection, denosumab, 1 mg	14	$20,599	None
Long return visit (40+ min)	104	$17,780	$120
Short return visit (20+ min)	114	$8,202	$70
Aspiration and/or injection of fluid from large joint	38	$3,401	$60
New patient visit (60+ min)	14	$2,403	$172
New patient visit (45+ min)	17	$2,212	$130
Telephone medical discussion with physician, 21-30 minutes	11	$916	$70
Injection, methylprednisolone acetate, 40 mg	44	$408	None
Injection of drug or substance under skin or into muscle	14	$248	$12

2020: 11 services

Sort by

Original Medicare services billed in 2020

Return visit (30+ min)	231	$26,109	$71
Injection, denosumab, 1 mg	11	$14,800	None
Long return visit (40+ min)	81	$12,966	$115
New patient visit (60+ min)	29	$4,040	$139
Aspiration and/or injection of fluid from large joint	34	$3,104	$54
Telephone medical discussion with physician, 21-30 minutes	30	$2,635	$85
Telephone medical discussion with physician, 11-20 minutes	27	$1,503	$56
New patient visit (45+ min)	15	$1,482	$99
Short return visit (20+ min)	24	$1,156	$48
Injection, methylprednisolone acetate, 40 mg	41	$382	None
Injection of drug or substance under skin or into muscle	11	$188	$12

2019: 9 services

Sort by

Original Medicare services billed in 2019

Return visit (30+ min)	259	$37,141	$76
Injection, denosumab, 1 mg	16	$21,145	None
Long return visit (40+ min)	43	$5,429	$113
New patient visit (45+ min)	44	$5,056	$115
New patient visit (60+ min)	26	$4,017	$155
Aspiration and/or injection of fluid from large joint	45	$3,861	$51
Short return visit (20+ min)	17	$1,149	$55
Injection, methylprednisolone acetate, 40 mg	47	$512	None
Injection of drug or substance under skin or into muscle	20	$451	$14

2018: 9 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	234	$31,978	$76
Injection, denosumab, 1 mg	20	$24,308	None
New patient visit (45+ min)	79	$8,938	$113
Long return visit (40+ min)	29	$2,999	$103
Aspiration and/or injection of fluid from large joint	42	$2,935	$47
New patient visit (60+ min)	12	$2,023	$169
Short return visit (20+ min)	27	$1,614	$49
Injection of drug or substance under skin or into muscle	21	$524	$17
Injection, methylprednisolone acetate, 40 mg	45	$371	None

2017: 9 services

Sort by

Original Medicare services billed in 2017

Return visit (30+ min)	211	$29,797	$77
Injection, denosumab, 1 mg	15	$15,193	None
New patient visit (45+ min)	78	$9,504	$122
Short return visit (20+ min)	37	$3,044	$55
Long return visit (40+ min)	24	$2,815	$117
Aspiration and/or injection of fluid from large joint	37	$2,763	$45
Injection of drug or substance under skin or into muscle	19	$505	$21
Injection, methylprednisolone acetate, 40 mg	43	$363	None
Injection, methylprednisolone acetate, 20 mg	14	$141	None

2016: 8 services

Sort by

Original Medicare services billed in 2016

Return visit (30+ min)	213	$29,137	$75
New patient visit (45+ min)	89	$10,652	$120
Long return visit (40+ min)	34	$3,686	$108
Aspiration and/or injection of fluid from large joint	30	$2,095	$44
Short return visit (20+ min)	31	$1,883	$47
Aspiration and/or injection of fluid from small joint	11	$691	$33
Injection, methylprednisolone acetate, 40 mg	38	$263	None
Injection, methylprednisolone acetate, 20 mg	16	$110	None

2015: 8 services

Sort by

Original Medicare services billed in 2015

Return visit (30+ min)	179	$25,421	$77
New patient visit (45+ min)	114	$13,331	$117
Short return visit (20+ min)	33	$2,461	$57
Aspiration and/or injection of fluid from large joint	24	$1,738	$56
Long return visit (40+ min)	14	$1,643	$117
Injection of drug or substance under skin or into muscle	15	$312	$19
Injection, methylprednisolone acetate, 40 mg	25	$124	None
Injection, methylprednisolone acetate, 20 mg	16	$51	None

2014: 9 services

Sort by

Original Medicare services billed in 2014

Return visit (30+ min)	176	$23,211	$81
New patient visit (45+ min)	99	$11,552	$117
Injection, denosumab, 1 mg	11	$8,806	None
Aspiration and/or injection of fluid from large joint	38	$2,343	$48
Short return visit (20+ min)	31	$1,580	$49
Injection of drug or substance under skin or into muscle	16	$550	$20
Aspiration and/or injection of fluid from small joint	11	$424	$28
Injection, methylprednisolone acetate, 40 mg	43	$126	None
Injection, methylprednisolone acetate, 20 mg	12	$37	None

2013: 7 services

Sort by

Original Medicare services billed in 2013

Return visit (30+ min)	209	$28,584	$74
New patient visit (45+ min)	126	$14,408	$114
Short return visit (20+ min)	84	$5,140	$56
Aspiration and/or injection of fluid from large joint	42	$2,605	$53
Aspiration and/or injection of fluid from small joint	11	$420	$35
Injection, methylprednisolone acetate, 40 mg	40	$105	None
Injection, methylprednisolone acetate, 20 mg	12	$34	None

Medicaid work

$2,173 in 2024

Medicaid paid $2,173 for 37 billed services this clinician did in 2024, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Return visit (30+ min)	37	$2,173

Sort by

Medicaid work by year

2024	37	1	13	$2,173
2023	127	1	21	$5,363
2022	102	1	49	$3,431
2021	442	3	36	$18,764
2020	263	2	35	$11,227
2019	253	1	28	$10,975
2018	199	1	23	$8,387

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Return visit (30+ min)	127	$5,363

2022

Sort by

Largest Medicaid services in 2022

Short return visit (20+ min)	102	$3,431

2021

Sort by

Largest Medicaid services in 2021

Return visit (30+ min)	224	$10,117
Long return visit (40+ min)	100	$5,358
Short return visit (20+ min)	118	$3,288

2020

Sort by

Largest Medicaid services in 2020

Return visit (30+ min)	250	$10,714
Short return visit (20+ min)	13	$513

2019

Sort by

Largest Medicaid services in 2019

Return visit (30+ min)	253	$10,975

2018

Sort by

Largest Medicaid services in 2018

Return visit (30+ min)	199	$8,387

Drugs they prescribed that Part D paid

$566,870

Pharmacies billed $566,870 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

576 generic and 126 brand-name prescriptions · $566,870 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Simponi	16	$104,028	$6,502
Humira(Cf)	12	$77,234	$6,436
Actemra	17	$77,227	$4,543
Benlysta	12	$66,102	$5,508
Actemra Actpen	13	$33,808	$2,601

See all 19 drugs

Sort by

Every Part D drug this clinician prescribed

Simponi	16	$104,028	$6,502
Humira(Cf)	12	$77,234	$6,436
Actemra	17	$77,227	$4,543
Benlysta	12	$66,102	$5,508
Actemra Actpen	13	$33,808	$2,601
Hydroxychloroquine Sulfate	127	$5,100	$40
Mycophenolate Mofetil	14	$2,951	$211
Celecoxib	28	$2,456	$88
Prednisone	126	$1,495	$12
Methylprednisolone	22	$1,115	$51
Methotrexate	50	$963	$19
Colchicine	17	$606	$36
Leflunomide	21	$558	$27
Allopurinol	26	$319	$12
Duloxetine	18	$233	$13
Gabapentin	23	$222	$10
Alendronate	30	$204	$7
Diclofenac	12	$92	$8
Meloxicam	17	$20	$1

Year by year

Sort by

Part D prescribing by year

2024	702	146	None	18%	$566,870
2023	536	123	0% (0)	18%	$517,007
2022	1,478	391	5% (69)	10%	$924,809
2021	3,432	505	11% (379)	None	$1,804,500
2020	3,019	476	8% (250)	None	$1,462,612
2019	2,681	457	9% (250)	None	$1,203,180
2018	2,318	378	8% (195)	22%	$1,179,568
2017	2,164	348	6% (137)	None	$1,075,377
2016	1,775	333	6% (104)	None	$648,195
2015	1,384	306	7% (99)	22%	$514,722
2014	906	263	11% (102)	17%	$156,555
2013	1,327	207	13% (177)	24%	$310,905

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 10 drugs

Sort by

Part D drugs prescribed in 2023

Actemra Actpen	20	$88,985	$4,449
Actemra	14	$58,988	$4,213
Hydroxychloroquine Sulfate	98	$4,332	$44
Prednisone	101	$1,394	$14
Methotrexate	27	$796	$29
Celecoxib	16	$430	$27
Allopurinol	19	$339	$18
Alendronate	35	$214	$6
Methylprednisolone	11	$150	$14
Gabapentin	20	$128	$6

2022: 29 drugs

Sort by

Part D drugs prescribed in 2022

Enbrel Sureclick	20	$157,425	$7,871
Orencia Clickject	22	$118,806	$5,400
Otezla	22	$95,507	$4,341
Humira(Cf)	11	$87,294	$7,936
Hydroxychloroquine Sulfate	252	$17,318	$69
Methotrexate	115	$4,169	$36
Gabapentin	131	$3,496	$27
Pregabalin	75	$2,848	$38
Celecoxib	53	$2,731	$52
Prednisone	159	$2,104	$13
Duloxetine	39	$1,773	$45
Leflunomide	15	$1,366	$91
Methylprednisolone	38	$1,177	$31
Diclofenac	36	$1,128	$31
Cyclobenzaprine	35	$1,019	$29
Allopurinol	53	$689	$13
Nabumetone	12	$677	$56
Alendronate	44	$547	$12
Leucovorin	14	$462	$33
Hydrocodone-Acetaminophen	12	$356	$30
Sulfasalazine	14	$350	$25
Tramadol	40	$293	$7
Tizanidine	14	$289	$21
Amitriptyline	14	$269	$19
Ibuprofen	14	$210	$15
Clonazepam	15	$160	$11
Folic Acid	22	$137	$6
Meloxicam	12	$101	$8
Omeprazole	11	$101	$9

2021: 41 drugs

Sort by

Part D drugs prescribed in 2021

Enbrel Sureclick	55	$432,781	$7,869
Humira(Cf)	21	$167,438	$7,973
Rinvoq	28	$153,646	$5,487
Orencia	20	$98,556	$4,928
Otezla	24	$97,738	$4,072
Orencia Clickject	15	$77,475	$5,165
Cosentyx Pen (2 Pens)	11	$69,432	$6,312
Simponi	12	$67,372	$5,614
Benlysta	12	$51,340	$4,278
Hydroxychloroquine Sulfate	485	$37,983	$78
Methotrexate	273	$12,069	$44
Celecoxib	155	$10,199	$66
Pregabalin	148	$8,883	$60
Gabapentin	332	$6,227	$19
Prednisone	304	$3,640	$12
Colchicine	20	$3,096	$155
Methylprednisolone	86	$3,055	$36
Nabumetone	59	$3,039	$52
Leflunomide	21	$2,641	$126
Diclofenac	75	$2,583	$34
Duloxetine	95	$2,099	$22
Oxycodone	66	$1,802	$27
Tramadol	198	$1,649	$8
Hydrocodone-Acetaminophen	55	$1,564	$28
Allopurinol	121	$1,408	$12
Tizanidine	38	$1,194	$31
Alendronate	86	$1,003	$12
Cyclobenzaprine	64	$984	$15
Leucovorin	31	$974	$31
Topiramate	13	$808	$62
Amitriptyline	29	$673	$23
Sulfasalazine	28	$624	$22
Acetaminophen-Codeine	22	$391	$18
Oxycodone-Acetaminophen	23	$338	$15
Morphine Sulfate Er	11	$259	$24
Baclofen	15	$247	$16
Ibuprofen	25	$243	$10
Meloxicam	20	$212	$11
Folic Acid	37	$160	$4
Clonazepam	18	$144	$8
Lorazepam	21	$121	$6

2020: 39 drugs

Sort by

Part D drugs prescribed in 2020

Enbrel Sureclick	38	$309,613	$8,148
Humira	18	$126,013	$7,001
Humira(Cf)	18	$114,903	$6,384
Simponi	11	$108,466	$9,861
Xeljanz	24	$104,371	$4,349
Orencia Clickject	13	$103,037	$7,926
Orencia	18	$94,895	$5,272
Cosentyx Pen (2 Pens)	15	$88,552	$5,903
Hydroxychloroquine Sulfate	414	$39,299	$95
Methotrexate	268	$12,573	$47
Celecoxib	167	$11,863	$71
Pregabalin	95	$8,458	$89
Gabapentin	254	$5,834	$23
Methylprednisolone	118	$4,968	$42
Leflunomide	31	$4,628	$149
Colchicine	20	$4,193	$210
Prednisone	316	$3,830	$12
Nabumetone	67	$2,272	$34
Allopurinol	128	$2,136	$17
Duloxetine	90	$1,760	$20
Diclofenac	62	$1,630	$26
Tizanidine	22	$1,228	$56
Amitriptyline	37	$1,188	$32
Oxycodone	30	$1,155	$38
Tramadol	143	$1,103	$8
Alendronate	91	$979	$11
Leucovorin	25	$972	$39
Etodolac	14	$902	$64
Cyclobenzaprine	50	$829	$17
Hydrocodone-Acetaminophen	29	$660	$23
Oxycodone-Acetaminophen	23	$476	$21
Baclofen	17	$467	$27
Ibuprofen	41	$467	$11
Pantoprazole	13	$453	$35
Sulfasalazine	12	$291	$24
Acetaminophen-Codeine	13	$279	$21
Meloxicam	29	$237	$8
Topiramate	18	$159	$9
Clonazepam	12	$77	$6

2019: 39 drugs

Sort by

Part D drugs prescribed in 2019

Enbrel Sureclick	32	$186,514	$5,829
Orencia	25	$145,441	$5,818
Humira	16	$118,544	$7,409
Cosentyx Pen (2 Pens)	19	$105,287	$5,541
Orencia Clickject	15	$105,263	$7,018
Lyrica	86	$68,449	$796
Xeljanz Xr	13	$61,750	$4,750
Hydroxychloroquine Sulfate	344	$43,497	$126
Otezla	11	$39,247	$3,568
Celecoxib	135	$14,302	$106
Methotrexate	253	$11,321	$45
Pregabalin	49	$7,121	$145
Methylprednisolone	122	$6,012	$49
Uloric	13	$5,576	$429
Gabapentin	214	$4,639	$22
Prednisone	310	$3,933	$13
Leflunomide	20	$3,205	$160
Nabumetone	51	$2,370	$46
Duloxetine	45	$2,074	$46
Allopurinol	90	$1,833	$20
Diclofenac	42	$1,601	$38
Colchicine	13	$1,547	$119
Tramadol	137	$1,446	$11
Oxycodone	41	$1,044	$25
Amitriptyline	32	$990	$31
Hydrocodone-Acetaminophen	30	$850	$28
Ibuprofen	27	$543	$20
Cyclobenzaprine	38	$540	$14
Alendronate	46	$512	$11
Baclofen	15	$447	$30
Leucovorin	29	$431	$15
Sulindac	16	$425	$27
Tizanidine	15	$394	$26
Sulfasalazine	18	$379	$21
Pantoprazole	17	$372	$22
Sulfasalazine Dr	11	$334	$30
Acetaminophen-Codeine	13	$253	$19
Oxycodone-Acetaminophen	17	$199	$12
Meloxicam	42	$174	$4

2018: 31 drugs

Sort by

Part D drugs prescribed in 2018

Enbrel Sureclick	67	$412,771	$6,161
Humira	34	$181,596	$5,341
Otezla	25	$78,987	$3,159
Lyrica	138	$75,612	$548
Orencia	15	$62,198	$4,147
Actemra	17	$46,490	$2,735
Hydroxychloroquine Sulfate	280	$45,661	$163
Methotrexate	282	$13,104	$46
Celecoxib	82	$5,744	$70
Colchicine	14	$5,228	$373
Gabapentin	188	$2,843	$15
Prednisone	248	$2,737	$11
Methylprednisolone	86	$2,667	$31
Duloxetine	44	$1,652	$38
Diclofenac	48	$1,547	$32
Nabumetone	37	$1,269	$34
Oxycodone	36	$1,220	$34
Tramadol	95	$1,102	$12
Allopurinol	57	$1,022	$18
Hydrocodone-Acetaminophen	27	$976	$36
Amitriptyline	37	$693	$19
Tizanidine	26	$668	$26
Etodolac	11	$534	$49
Acetaminophen-Codeine	25	$492	$20
Cyclobenzaprine	44	$472	$11
Leucovorin	20	$469	$23
Alendronate	39	$273	$7
Meloxicam	28	$214	$8
Clonazepam	15	$205	$14
Ibuprofen	12	$131	$11
Ropinirole	12	$80	$7

2017: 29 drugs

Sort by

Part D drugs prescribed in 2017

Enbrel Sureclick	85	$439,966	$5,176
Humira	27	$122,849	$4,550
Xeljanz	15	$66,714	$4,448
Humira	13	$58,863	$4,528
Lyrica	116	$55,012	$474
Hydroxychloroquine Sulfate	268	$44,849	$167
Cimzia	11	$42,514	$3,865
Methotrexate	285	$12,560	$44
Celecoxib	91	$7,558	$83
Colchicine	26	$4,372	$168
Methylprednisolone	62	$3,030	$49
Leflunomide	15	$2,889	$193
Prednisone	236	$2,350	$10
Gabapentin	163	$2,171	$13
Diclofenac	41	$2,051	$50
Duloxetine	32	$1,425	$45
Tramadol	96	$1,111	$12
Allopurinol	70	$1,014	$14
Tizanidine	45	$974	$22
Amitriptyline	36	$584	$16
Sulfasalazine	11	$435	$40
Nabumetone	15	$384	$26
Alendronate	56	$371	$7
Meloxicam	40	$297	$7
Oxycodone	11	$293	$27
Hydrocodone-Acetaminophen	12	$217	$18
Cyclobenzaprine	35	$195	$6
Acetaminophen-Codeine	12	$172	$14
Methotrexate	15	$95	$6

2016: 27 drugs

Sort by

Part D drugs prescribed in 2016

Enbrel	38	$185,661	$4,886
Humira	29	$144,043	$4,967
Xeljanz	18	$60,054	$3,336
Hydroxychloroquine Sulfate	371	$55,251	$149
Otezla	13	$33,026	$2,540
Lyrica	55	$22,265	$405
Methotrexate	193	$8,180	$42
Celecoxib	68	$7,801	$115
Colchicine	17	$4,147	$244
Leflunomide	20	$3,061	$153
Gabapentin	97	$2,628	$27
Prednisone	223	$2,393	$11
Methylprednisolone	49	$1,986	$41
Duloxetine	32	$1,352	$42
Etodolac	20	$1,147	$57
Diclofenac	18	$994	$55
Tramadol	66	$831	$13
Allopurinol	47	$798	$17
Voltaren	12	$579	$48
Alendronate	72	$540	$7
Nabumetone	23	$487	$21
Hydrocodone-Acetaminophen	13	$325	$25
Amitriptyline	34	$324	$10
Tizanidine	21	$312	$15
Meloxicam	69	$292	$4
Acetaminophen-Codeine	11	$154	$14
Cyclobenzaprine	18	$69	$4

2015: 20 drugs

Sort by

Part D drugs prescribed in 2015

Enbrel	44	$190,101	$4,320
Humira	42	$155,777	$3,709
Hydroxychloroquine Sulfate	261	$39,947	$153
Lyrica	36	$11,162	$310
Methotrexate	160	$9,883	$62
Celecoxib	36	$9,299	$258
Methylprednisolone	61	$2,729	$45
Prednisone	178	$2,071	$12
Duloxetine	31	$1,882	$61
Gabapentin	63	$1,385	$22
Etodolac	25	$1,159	$46
Leflunomide	14	$986	$70
Tramadol	80	$666	$8
Nabumetone	13	$578	$44
Alendronate	58	$428	$7
Allopurinol	29	$369	$13
Leucovorin	23	$331	$14
Cyclobenzaprine	21	$246	$12
Meloxicam	57	$233	$4
Amitriptyline	20	$141	$7

2014: 19 drugs

Sort by

Part D drugs prescribed in 2014

Humira	22	$69,967	$3,180
Methotrexate	134	$9,700	$72
Celebrex	18	$9,347	$519
Colcrys	22	$4,636	$211
Lyrica	12	$3,411	$284
Duloxetine	24	$3,268	$136
Hydroxychloroquine Sulfate	100	$2,609	$26
Methylprednisolone	33	$1,775	$54
Etodolac	41	$1,584	$39
Prednisone	127	$1,539	$12
Tramadol	61	$938	$15
Gabapentin	40	$872	$22
Alendronate	39	$527	$14
Hydrocodone-Acetaminophen	13	$428	$33
Oxycodone	11	$425	$39
Allopurinol	36	$296	$8
Meloxicam	25	$146	$6
Cyclobenzaprine	12	$94	$8
Amitriptyline	13	$74	$6

2013: 26 drugs

Sort by

Part D drugs prescribed in 2013

Humira	50	$140,892	$2,818
Enbrel	41	$104,445	$2,547
Colcrys	66	$11,840	$179
Lyrica	39	$8,928	$229
Celebrex	26	$6,282	$242
Methotrexate	101	$5,328	$53
Cymbalta	20	$4,378	$219
Hydroxychloroquine Sulfate	155	$2,788	$18
Nabumetone	60	$1,637	$27
Leflunomide	29	$1,249	$43
Prednisone	131	$1,023	$8
Gabapentin	44	$982	$22
Tizanidine	18	$809	$45
Etodolac	23	$797	$35
Oxycodone	30	$794	$26
Cyclobenzaprine	58	$769	$13
Tramadol	63	$614	$10
Acetaminophen-Codeine	29	$442	$15
Alendronate	38	$356	$9
Meloxicam	26	$291	$11
Oxycodone-Acetaminophen	30	$259	$9
Azathioprine	12	$256	$21
Allopurinol	46	$254	$6
Indomethacin	13	$247	$19
Omeprazole	22	$234	$11
Amitriptyline	17	$165	$10

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1861693228
Licence: CA C175548California C175548: Current · expires 2027-11-30
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Male

More record details

Sole proprietor: No
Medicaid ID: NH 3081927
Taxonomy: Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2007-05-31
NPI last updated: 2024-04-15
NPI record certified: 2024-04-15

This is when the NPI record was last certified, not a medical board exam.